Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 851256, 9 pages
http://dx.doi.org/10.1155/2013/851256
Research Article

A Study on the Mechanism of Cinobufagin in the Treatment of Paw Cancer Pain by Modulating Local β-Endorphin Expression In Vivo

1College of Medical Science, China Three Gorges University, 8 University Avenue, Yichang, Hubei 443002, China
2Third-Grade Pharmacological Laboratory on Traditional Chinese Medicine Approved by State Administration of Traditional Chinese Medicine, Yichang, Hubei 443002, China
3Hubei Key Laboratory of Natural Products Research and Development, China Three Gorges University, Yichang, Hubei 443002, China

Received 14 June 2013; Revised 4 August 2013; Accepted 25 August 2013

Academic Editor: Shrikant Anant

Copyright © 2013 Tao Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q.-L. Mao-Ying, J. Zhao, Z.-Q. Dong et al., “A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells,” Biochemical and Biophysical Research Communications, vol. 345, no. 4, pp. 1292–1298, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Meuser, C. Pietruck, L. Radbruch, P. Stute, K. A. Lehmann, and S. Grond, “Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology,” Pain, vol. 93, no. 3, pp. 247–257, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Herz, “Role of immune processes in peripheral opioid analgesia,” Advances in Experimental Medicine and Biology, vol. 373, pp. 193–199, 1995. View at Google Scholar · View at Scopus
  4. H. Machelska, “Control of neuropathic pain by immune cells and opioids,” CNS and Neurological Disorders, vol. 10, no. 5, pp. 559–570, 2011. View at Google Scholar · View at Scopus
  5. H. MacHelska, “Dual peripheral actions of immune cells in neuropathic pain,” Archivum Immunologiae et Therapiae Experimentalis, vol. 59, no. 1, pp. 11–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. J. Cabot, L. Carter, C. Gaiddon et al., “Immune cell-derived β-endorphin: production, release, and control of inflammatory pain in rats,” Journal of Clinical Investigation, vol. 100, no. 1, pp. 142–148, 1997. View at Google Scholar · View at Scopus
  7. H. Machelska and C. Stein, “Leukocyte-derived opioid peptides and inhibition of pain,” Journal of Neuroimmune Pharmacology, vol. 1, no. 1, pp. 90–97, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. G. Tang, Z. X. Wei, and J. F. Yin, “46 cases on cinobufagin combined with chemotherapy in the treatment of advanced liver cancer,” Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, vol. 9, article 54, 1999. View at Google Scholar
  9. Y. Q. Lai, Y. Jin, and Y. Y. Chen, “Clinical Analysis on Cinobufotalin combined with chemotherapy in the treatment of advanced liver cancer,” Shaanxi Oncology, vol. 10, article 217, 2002. View at Google Scholar
  10. J. Shi, L. Xu, and P. K. Wei, “Clinical Observation of 17 cases on cinobufagin injection in acupoint injection in the treatment of cancer pain,” Chinese Journal Integrated Traditional Western Medicine, vol. 22, article 121, 2002. View at Google Scholar
  11. Z. Q. Zhang, Y. Wang, and D. Q. Rong, “Recent Curative Effect on cinobufotalin combined with HCPT in treatment of advanced gastric cancer,” Practical Journal Medical Pharmacology, vol. 23, pp. 794–795, 2006. View at Google Scholar
  12. Y. H. Wang, “Cinobufotalin combined with chemotherapy in the treatment of advanced gastric cancer in 36 cases,” Jiangxi Journal Traditional Chinese Medicine, vol. 40, pp. 31–32, 2009. View at Google Scholar
  13. Z. P. Gong and T. Chen, “Studies on analgesic mechanism based on opioid receptor for cinobufagin injection,” Chinese Journal Experimental Traditional Medical Formulae, vol. 16, pp. 120–122, 2010. View at Google Scholar
  14. J. Z. Wang, J. Yan, and J. Zhang, “Studies on the analgesic effect of cinobufacini injection and its mechanism,” Journal Linyi Medical College, vol. 22, pp. 81–84, 2000. View at Google Scholar
  15. Y. P. Zhang, Pharmacology Experiment, People's Medical Publishing House, Beijing, China, 2nd edition, 1996, chinese.
  16. H. Asai, N. Ozaki, M. Shinoda et al., “Heat and mechanical hyperalgesia in mice model of cancer pain,” Pain, vol. 117, no. 1-2, pp. 19–29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. B. L. Schmidt, V. Pickering, S. Liu et al., “Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain,” European Journal of Pain, vol. 11, no. 4, pp. 406–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. P. N. Quang and B. L. Schmidt, “Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice,” Journal of Pain, vol. 11, no. 7, pp. 663–671, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. W. Wacnik, L. J. Eikmeier, T. R. Ruggles et al., “Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain,” Journal of Neuroscience, vol. 21, no. 23, pp. 9355–9366, 2001. View at Google Scholar · View at Scopus
  20. H. Vermeirsch, R. M. Nuydens, P. L. Salmon, and T. F. Meert, “Bone cancer pain model in mice: evaluation of pain behavior, bone destruction and morphine sensitivity,” Pharmacology Biochemistry and Behavior, vol. 79, no. 2, pp. 243–251, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. J. Medhurst, K. Walker, M. Bowes et al., “A rat model of bone cancer pain,” Pain, vol. 96, no. 1-2, pp. 129–140, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Doré-Savard, V. Otis, K. Bellevill et al., “Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain,” PLoS ONE, vol. 5, no. 10, Article ID e13774, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Zhang and L. Lao, “A new rat model of bone cancer pain,” Methods in Molecular Biology, vol. 851, pp. 261–273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Wang, R. Zhang, C. Dong et al., “Topical treatment with Tong-Luo-San-Jie gel alleviates bone cancer pain in rats,” Journal of Ethnopharmacology, vol. 143, pp. 905–913, 2012. View at Google Scholar
  25. B. H. Lee, J. Seong, U. J. Kim, R. Won, and J. Kim, “Behavioral characteristics of a mouse model of cancer pain,” Yonsei Medical Journal, vol. 46, no. 2, pp. 252–259, 2005. View at Google Scholar · View at Scopus
  26. M. E. Mouedden and T. F. Meert, “Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain,” Pharmacology Biochemistry and Behavior, vol. 82, no. 1, pp. 109–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Sitte, M. Busch, S. A. Mousa et al., “Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo,” Journal of Neuroimmunology, vol. 183, no. 1-2, pp. 133–145, 2007. View at Publisher · View at Google Scholar · View at Scopus